KFS
Kelly Financial Services Portfolio holdings
AUM
$339M
This Quarter Return
-13.6%
1 Year Return
+12.04%
3 Year Return
+48.57%
5 Year Return
+68.33%
10 Year Return
–
AUM
$81.1M
AUM Growth
+$81.1M
(-38%)
Cap. Flow
-$20.2M
Cap. Flow
% of AUM
-24.94%
Top 10 Holdings %
Top 10 Hldgs %
84.98%
Holding
613
New
49
Increased
139
Reduced
48
Closed
31
Top Buys
| 1 |
SPDR Gold Trust
GLD
|
$10.6M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
$5.32M |
| 3 |
SPDR Portfolio Short Term Treasury ETF
SPTS
|
$3.99M |
| 4 |
iShares Core Dividend Growth ETF
DGRO
|
$910K |
| 5 |
iShares US Utilities ETF
IDU
|
$689K |
Top Sells
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
$12.6M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$12.6M |
| 3 |
Fidelity MSCI Health Care Index ETF
FHLC
|
$9.73M |
| 4 |
iShares US Aerospace & Defense ETF
ITA
|
$6.75M |
| 5 |
Sherwin-Williams
SHW
|
$460K |
Sector Composition
| 1 | Healthcare | 3.48% |
| 2 | Technology | 3.17% |
| 3 | Materials | 2.67% |
| 4 | Financials | 2.03% |
| 5 | Industrials | 1.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Navient
NAVI
$1.36B
| – | – | -100 | Closed | -$1.37K |
|
602
Phio Pharmaceuticals
PHIO
$11.3M
| – | – | -5 | Closed | -$1 |
|
603
RTX Corp
RTX
$212B
| – | – | -534 | Closed | -$79.9K |
|
604
Sumitomo Mitsui Financial
SMFG
$105B
| – | – | -404 | Closed | -$2.99K |
|
605
Tandem Diabetes Care
TNDM
$845M
| – | – | -150 | Closed | -$8.94K |
|
606
UBS Group
UBS
$128B
| – | – | -340 | Closed | -$4.28K |
|
607
United Rentals
URI
$61.5B
| – | – | -22 | Closed | -$3.67K |
|
608
Vanguard FTSE Developed Markets ETF
VEA
$171B
| – | – | -418 | Closed | -$18.4K |
|
|
S
609
DELISTED
Sprint Corporation
S
| – | – | -3,437 | Closed | -$17.9K |
|
|
MDR
610
DELISTED
McDermott International
MDR
| – | – | -5 | Closed | -$3 |
|
|
DTYS
611
DELISTED
iPath US Treasury 10-year Bear ETN
DTYS
| – | – | -180 | Closed | -$2.32K |
|
|
CNHX
612
DELISTED
CSOP MSCI China A International Hedged ETF
CNHX
| – | – | -460 | Closed | -$12.5K |
|
|
GCVRZ
613
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| – | – | -75 | Closed | -$65 |
|